Pegargiminase Unknown Status Phase 2 Trials for Malignant Pleural Mesothelioma (MPM) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01279967A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma